$5.290
-0.146 (-2.76%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de VNDA por análisis de gráficos similares
Alphio's VNDA stock price prediction model matches the current Vanda Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.31 (+0.39%). The 1-week path is $5.25 (-0.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Vanda Pharmaceuticals Inc?
Vanda Pharmaceuticals Inc is currently a hold. The stock is priced at $5.29, significantly below its analyst price target of $14.13, suggesting potential for growth. However, the company has reported a substantial net loss of $62.51 million in Q2 2026, which raises concerns about its profitability and future cash flow. Additionally, the RSI is at 46.31, indicating a neutral momentum, and insider selling has increased by 972.59%, which may signal a lack of confidence among insiders. Given these mixed signals, it may be prudent to wait for clearer signs of recovery before making a purchase.
VNDA cerró en $5.29 el Friday, tras bajar -2.76%
Vanda Pharmaceuticals Inc (VNDA) last closed at $5.29, losing -2.76%. These facts feed the 1-day and 1-week VNDA price prediction above.
Consenso de analistas
Vanda Pharmaceuticals Inc (VNDA): 5 comprar, 0 mantener, 1 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Vanda Pharmaceuticals Inc (VNDA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de VNDA, ordenadas por similitud.
Análisis de estacionalidad de VNDA
Historically the probability of a positive August return for VNDA is 34.92%. December offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de VNDA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $4.70 | $5.60 | $6.62 | +5.84% |
| Sep 2026 | $4.89 | $5.72 | $6.20 | +8.08% |
| Oct 2026 | $4.98 | $5.50 | $6.64 | +4.06% |
| Nov 2026 | $4.91 | $6.02 | $7.09 | +13.87% |
| Dec 2026 | $4.78 | $5.69 | $6.72 | +7.57% |
En 2026, se proyecta que Vanda Pharmaceuticals Inc (VNDA) oscile entre $4.70 y $7.09.
Previsión mensual de Vanda Pharmaceuticals Inc para 2026
En Aug de 2026, se proyecta que Vanda Pharmaceuticals Inc promedie $5.60, con un mínimo de $4.70 y un máximo de $6.62.
En Sep de 2026, se proyecta que Vanda Pharmaceuticals Inc promedie $5.72, con un mínimo de $4.89 y un máximo de $6.20.
En Oct de 2026, se proyecta que Vanda Pharmaceuticals Inc promedie $5.50, con un mínimo de $4.98 y un máximo de $6.64.
En Nov de 2026, se proyecta que Vanda Pharmaceuticals Inc promedie $6.02, con un mínimo de $4.91 y un máximo de $7.09.
En Dec de 2026, se proyecta que Vanda Pharmaceuticals Inc promedie $5.69, con un mínimo de $4.78 y un máximo de $6.72.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.